Morizane Y, Morimoto N, Fujiwara A, Kawasaki R, Yamashita H, Ogura Y, Shiraga F (2018) Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals. Jpn J Ophthalmol. https://doi.org/10.1007/s10384-018-0623-4

Article  PubMed  Google Scholar 

Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358:2606–2617. https://doi.org/10.1056/NEJMra0801537

Article  CAS  PubMed  Google Scholar 

Yamashiro K, Oishi A, Hata M, Takahashi A, Tsujikawa A (2021) Visual acuity outcomes of anti-VEGF treatment for neovascular age-related macular degeneration in clinical trials. Jpn J Ophthalmol 65:741–760. https://doi.org/10.1007/s10384-021-00869-x

Article  PubMed  Google Scholar 

Tamura H, Akune Y, Hiratsuka Y, Kawasaki R, Kido A, Miyake M, Goto R, Yamada M (2022) Real-world effectiveness of screening programs for age-related macular degeneration: amended Japanese specific health checkups and augmented screening programs with OCT or AI. Jpn J Ophthalmol 66:19–32. https://doi.org/10.1007/s10384-021-00890-0

Article  PubMed  Google Scholar 

Bloch SB, Larsen M, Munch IC (2012) Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010. Am J Ophthalmol 153(209–213):e202. https://doi.org/10.1016/j.ajo.2011.10.016

Article  Google Scholar 

Pauleikhoff D (2005) neovascular age-related macular degeneration: natural history and treatment outcomes. Retina 25:1065–1084. https://doi.org/10.1097/00006982-200512000-00016

Article  PubMed  Google Scholar 

Mettu PS, Allingham MJ, Cousins SW (2021) Incomplete response to Anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities. Prog Retin Eye Res 82:100906. https://doi.org/10.1016/j.preteyeres.2020.100906

Article  CAS  PubMed  Google Scholar 

Albini A, Tosetti F, Li VW, Noonan DM, Li WW (2012) Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol 9:498–509. https://doi.org/10.1038/nrclinonc.2012.120

Article  CAS  PubMed  Google Scholar 

Sitohy B, Nagy JA, Dvorak HF (2012) Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res 72:1909–1914. https://doi.org/10.1158/0008-5472.CAN-11-3406

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mancuso MR, Davis R, Norberg SM, O’Brien S, Sennino B, Nakahara T, Yao VJ, Inai T, Brooks P, Freimark B, Shalinsky DR, Hu-Lowe DD, McDonald DM (2006) Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 116:2610–2621. https://doi.org/10.1172/JCI24612

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah RS, Soetikno BT, Lajko M, Fawzi AA (2015) A mouse model for laser-induced choroidal neovascularization. J Vis Exp: e53502 https://doi.org/10.3791/53502

Zandi S, Nakao S, Chun KH, Fiorina P, Sun D, Arita R, Zhao M, Kim E, Schueller O, Campbell S, Taher M, Melhorn MI, Schering A, Gatti F, Tezza S, Xie F, Vergani A, Yoshida S, Ishikawa K, Yamaguchi M, Sasaki F, Schmidt-Ullrich R, Hata Y, Enaida H, Yuzawa M, Yokomizo T, Kim YB, Sweetnam P, Ishibashi T, Hafezi-Moghadam A (2015) ROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration. Cell Rep 10:1173–1186. https://doi.org/10.1016/j.celrep.2015.01.050

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431. https://doi.org/10.1056/NEJMoa054481

Article  Google Scholar 

Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K, Group S-US (2013) Seven-year outcomes in ranibizumab-treated patients in Anchor, Marina, and Horizon: a multicenter cohort study (SEVEN-UP). Ophthalmology 120:2292–2299. https://doi.org/10.1016/j.ophtha.2013.03.046

Article  Google Scholar 

Wada I, Oshima Y, Shiose S, Kano K, Nakao S, Kaizu Y, Yoshida S, Ishibashi T, Sonoda KH (2019) Five-year treatment outcomes following intravitreal ranibizumab injections for neovascular age-related macular degeneration in Japanese patients. Graefes Arch Clin Exp Ophthalmol 257:1411–1418. https://doi.org/10.1007/s00417-019-04361-8

Article  CAS  PubMed  Google Scholar 

Ciulla TA, Hussain RM, Taraborelli D, Pollack JS, Williams DF (2022) Longer-term anti-VEGF therapy outcomes in neovascular age-related macular degeneration, diabetic macular edema, and vein occlusion-related macular edema: clinical outcomes in 130 247 Eyes. Ophthalmol Retina 6:796–806. https://doi.org/10.1016/j.oret.2022.03.021

Article  PubMed  Google Scholar 

Muakkassa NW, Chin AT, de Carlo T, Klein KA, Baumal CR, Witkin AJ, Duker JS, Waheed NK (2015) Characterizing the effect of anti-vascular endothelial growth factor therapy on treatment-naive choroidal neovascularization using optical coherence tomography angiography. Retina 35:2252–2259. https://doi.org/10.1097/IAE.0000000000000836

Article  CAS  PubMed  Google Scholar 

Takeuchi J, Kataoka K, Ito Y, Takayama K, Yasuma T, Kaneko H, Terasaki H (2018) Optical coherence tomography angiography to quantify choroidal neovascularization in response to aflibercept. Ophthalmologica 240:90–98. https://doi.org/10.1159/000487611

Article  CAS  PubMed  Google Scholar 

Sun D, Nakao S, Xie F, Zandi S, Bagheri A, Kanavi MR, Samiei S, Soheili ZS, Frimmel S, Zhang Z, Ablonczy Z, Ahmadieh H, Hafezi-Moghadam A (2014) Molecular imaging reveals elevated VEGFR-2 expression in retinal capillaries in diabetes: a novel biomarker for early diagnosis. FASEB J 28:3942–3951. https://doi.org/10.1096/fj.14-251934

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT (2006) Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168:2036–2053. https://doi.org/10.2353/ajpath.2006.050588

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakao S, Zandi S, Lara-Castillo N, Taher M, Ishibashi T, Hafezi-Moghadam A (2012) Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltration. Invest Ophthalmol Vis Sci 53:3296–3302. https://doi.org/10.1167/iovs.11-8114

Article  CAS  PubMed  PubMed Central  Google Scholar 

Archer DB, Gardiner TA (1981) Electron microscopic features of experimental choroidal neovascularization. Am J Ophthalmol 91:433–457. https://doi.org/10.1016/0002-9394(81)90230-0

Article  CAS  PubMed  Google Scholar 

Strittmatter K, Pomeroy H, Marneros AG (2016) Targeting platelet-derived growth factor receptor beta(+) scaffold formation inhibits choroidal neovascularization. Am J Pathol 186:1890–1899. https://doi.org/10.1016/j.ajpath.2016.02.018

Article  CAS  PubMed  Google Scholar 

Dong A, Seidel C, Snell D, Ekawardhani S, Ahlskog JK, Baumann M, Shen J, Iwase T, Tian J, Stevens R, Hackett SF, Stumpp MT, Campochiaro PA (2014) Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A. Angiogenesis 17:553–562. https://doi.org/10.1007/s10456-013-9402-5

Article  CAS  PubMed  Google Scholar 

Abramsson A, Lindblom P, Betsholtz C (2003) Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 112:1142–1151. https://doi.org/10.1172/JCI18549

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunn EN, Hariprasad SM, Sheth VS (2017) An overview of the Fovista and Rinucumab trials and the fate of anti-PDGF medications. Ophthalmic Surg Lasers Imaging Retina 48:100–104. https://doi.org/10.3928/23258160-20170130-02

Article  PubMed  Google Scholar 

Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY, Tenaya IL (2022) Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Lancet 399:729–740. https://doi.org/10.1016/S0140-6736(22)00010-1

Article  CAS  PubMed  Google Scholar 

Ishikawa K, Sreekumar PG, Spee C, Nazari H, Zhu D, Kannan R, Hinton DR (2016) alphaB-Crystallin regulates subretinal fibrosis by modulation of epithelial-mesenchymal transition. Am J Pathol 186:859–873. https://doi.org/10.1016/j.ajpath.2015.11.014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park SJ, Choi Y, Na YM, Hong HK, Park JY, Park KH, Chung JY, Woo SJ (2016) Intraocular pharmacokinetics of intravitreal aflibercept (Eylea) in a rabbit model. Invest Ophthalmol Vis Sci 57:2612–2617. https://doi.org/10.1167/iovs.16-19204

Article  CAS  PubMed  Google Scholar